Literature DB >> 9364976

Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response.

I Holm1, F Nato, K N Mendis, S Longacre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364976     DOI: 10.1016/s0166-6851(97)00128-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  11 in total

1.  Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.

Authors:  Sheetij Dutta; Deep C Kaushal; Lisa A Ware; Sunil K Puri; Nuzhat A Kaushal; Atul Narula; D S Upadhyaya; David E Lanar
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Secretion of parasite-specific immunoglobulin G by purified blood B lymphocytes from immune individuals after in vitro stimulation with recombinant Plasmodium falciparum merozoite surface protein-119 antigen.

Authors:  O Garraud; A Diouf; I Holm; C M Nguer; A Spiegel; R Perraut; S Longacre
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

3.  Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with MSP119.

Authors:  O Garraud; A Diouf; I Holm; R Perraut; S Longacre
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

4.  Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria.

Authors:  K L Perera; S M Handunnetti; I Holm; S Longacre; K Mendis
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.

Authors:  Suraksha Sachdeva; Gul Ahmad; Pawan Malhotra; Paushali Mukherjee; V S Chauhan
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils.

Authors:  Charlotte Joos; Marie-Louise Varela; Babacar Mbengue; Annick Mansourou; Laurence Marrama; Cheikh Sokhna; Adama Tall; Jean-François Trape; Aissatou Touré; Odile Mercereau-Puijalon; Ronald Perraut
Journal:  Malar J       Date:  2015-10-15       Impact factor: 2.979

7.  Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria.

Authors:  Ronald Perraut; Charlotte Joos; Cheikh Sokhna; Hannah E J Polson; Jean-François Trape; Adama Tall; Laurence Marrama; Odile Mercereau-Puijalon; Vincent Richard; Shirley Longacre
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

8.  Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.

Authors:  David Koffi; Marie-Louise Varela; Cheikh Loucoubar; Sylvain Beourou; Inès Vigan-Womas; Aissatou Touré; Joseph Allico Djaman; André Offianan Touré; Ronald Perraut
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

9.  Semisynthesis of Functional Glycosylphosphatidylinositol-Anchored Proteins.

Authors:  Renée F Roller; Ankita Malik; Maria A Carillo; Monika Garg; Antonella Rella; Marie-Kristin Raulf; Bernd Lepenies; Peter H Seeberger; Daniel Varón Silva
Journal:  Angew Chem Int Ed Engl       Date:  2020-05-18       Impact factor: 15.336

10.  New insights for native production of MSP1(19), the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1.

Authors:  Anne-Gaëlle Planson; J Iñaki Guijarro; Alain F Chaffotte
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.